๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer NCT05538091Phase 21 site๐Ÿ“ Pittsburgh Ronald Buckanovich ยท Tests: Vismodegib, Atezolizumab Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers NCT03564340Phase 1, Phase 254 sites๐Ÿ“ Birmingham๐Ÿ“ Boston๐Ÿ“ Boston Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Cemiplimab, Sarilumab, Tocilizumab A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites๐Ÿ“ Beverly Hills๐Ÿ“ San Francisco๐Ÿ“ Westwood, Los Angeles Fore Biotherapeutics ยท Tests: Plixorafenib A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) NCT05429970NA7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Mind-body resilience training, Music therapy, Propranolol, Etodolac Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer NCT07023484Phase 26 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen๐Ÿ“ Chai Wan The University of Hong Kong ยท Tests: KELIM, Carboplatin plus Paclitaxel, Interval debulking surgery Registry Platform Ovarian and Endometrial Cancer NCT05129969n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG ยท Tests: Physician's choice according to patient's needs. MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site๐Ÿ“ Scottsdale Mayo Clinic ยท Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin A Study to Evaluate Folate Receptor Alpha (FRฮฑ) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy NCT07407062n/a1 site๐Ÿ“ Rome AbbVie Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT07665515Phase 110 sites๐Ÿ“ Cambridge๐Ÿ“ Edinburgh๐Ÿ“ Glasgow Epitopea Ltd ยท Tests: CryptiVax-1001 Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer NCT06787612Phase 256 sites๐Ÿ“ Birmingham๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Bevacizumab, Cemiplimab, Fianlimab, PLD A Study of SHR-A1811 in Subjects With Ovarian Cancer NCT06828354Phase 32 sites๐Ÿ“ Wuhan๐Ÿ“ Jinan Jiangsu HengRui Medicine Co., Ltd. ยท Tests: SHR-A1811, Paclitaxel Injection, Doxorubicin Hydrochloride Liposome Injection, Gemcitabine Hydrochloride for Injection,โ€ฆ Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage NRG Oncology ยท Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer NCT07851025Phase 3186 sites๐Ÿ“ Tampa๐Ÿ“ Baltimore๐Ÿ“ Billings AstraZeneca ยท Tests: Torvutatug samrotecan, Bevacizumab A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Little Rock Artios Pharma Ltd ยท Tests: ART0380, Gemcitabine, Irinotecan Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial NCT04575935Phase 319 sites๐Ÿ“ Miami๐Ÿ“ Weston๐Ÿ“ Boston M.D. Anderson Cancer Center ยท Tests: Chemotherapy, Laparotomy, Minimally Invasive Surgery, Quality-of-Life Assessment, Questionnaire Administration Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer NCT05200260Phase 29 sites๐Ÿ“ Foshan๐Ÿ“ Guangzhou๐Ÿ“ Hangzhou Shanghai Gynecologic Oncology Group ยท Tests: Primary debulking surgery, Neoadjuvant chemotherapy, PARP inhibitor, Bevacizumab PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer NCT07472140Phase 2, Phase 31 site๐Ÿ“ Minsk N.N. Alexandrov National Cancer Centre ยท Tests: PARP inhibitor + Bevacizumab, PARP inhibitor Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors NCT07586826Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Romiplostim N01, All-trans retinoic acid Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer NCT05737303Phase 311 sites๐Ÿ“ Guangzhou๐Ÿ“ Ji'nan๐Ÿ“ Hangzhou Women's Hospital School Of Medicine Zhejiang University ยท Tests: nab-paclitaxel combined with carboplatin MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites๐Ÿ“ Graz๐Ÿ“ Graz๐Ÿ“ Innsbruck Swiss GO Trial Group ยท Tests: Letrozole 2.5mg, Placebo Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer NCT06856499Phase 12 sites๐Ÿ“ Aurora๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Cirtuvivint, Olaparib A Study of Sovilnesib in Subjects With Ovarian Cancer NCT06084416Phase 111 sites๐Ÿ“ Birmingham๐Ÿ“ Little Rock๐Ÿ“ Newport Beach Volastra Therapeutics, Inc. ยท Tests: Sovilnesib Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer NCT07816666Phase 3124 sites๐Ÿ“ Anchorage๐Ÿ“ Miami๐Ÿ“ Indianapolis AstraZeneca ยท Tests: Torvutatug samrotecan, Bevacizumab Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial NCT05564377Phase 2484 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Alpelisib, Binimetinib, Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine NCT06682988Phase 252 sites๐Ÿ“ Sarasota๐Ÿ“ Edgewood๐Ÿ“ Lexington AbbVie ยท Tests: Mirvetuximab Soravtansine Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype NCT05574673n/a1 site๐Ÿ“ Kรธbenhavn ร˜ Nordic Society of Gynaecological Oncology - Clinical Trialsโ€ฆ ยท Tests: Standard of care A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers NCT07708753Phase 31 site๐Ÿ“ Beijing CSPC Megalith Biopharmaceutical Co.,Ltd. ยท Tests: SYS6043, Liposomal doxorubicin, paclitaxel, or topotecan HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer NCT06855069Phase 31 site๐Ÿ“ Beijing Hansoh BioMedical R&D Company ยท Tests: HS-20089, Paclitaxel, Doxorubicin, Topotecan
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy